News stories about Varian Medical Systems (NYSE:VAR) have been trending somewhat positive this week, Accern reports. The research firm rates the sentiment of news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Varian Medical Systems earned a media sentiment score of 0.15 on Accern’s scale. Accern also assigned media stories about the medical equipment provider an impact score of 45.2462723493869 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
Here are some of the news articles that may have effected Accern Sentiment Analysis’s analysis:
VAR has been the subject of a number of research analyst reports. Citigroup upped their price objective on shares of Varian Medical Systems from $128.00 to $132.00 and gave the stock a “buy” rating in a research report on Thursday, January 25th. Zacks Investment Research upgraded shares of Varian Medical Systems from a “hold” rating to a “buy” rating and set a $142.00 price objective for the company in a research report on Tuesday, March 13th. ValuEngine upgraded shares of Varian Medical Systems from a “hold” rating to a “buy” rating in a research report on Thursday, March 1st. TheStreet cut shares of Varian Medical Systems from a “b+” rating to a “c” rating in a research report on Monday, February 12th. Finally, BTIG Research reiterated a “hold” rating on shares of Varian Medical Systems in a research report on Sunday, January 28th. Three research analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $111.80.
NYSE VAR traded down $2.83 on Friday, hitting $117.64. The company’s stock had a trading volume of 575,865 shares, compared to its average volume of 506,532. Varian Medical Systems has a 1-year low of $87.49 and a 1-year high of $130.29. The stock has a market cap of $10,740.53, a P/E ratio of 32.68, a price-to-earnings-growth ratio of 3.41 and a beta of 0.82.
Varian Medical Systems (NYSE:VAR) last announced its quarterly earnings results on Wednesday, January 24th. The medical equipment provider reported $1.06 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.00 by $0.06. Varian Medical Systems had a net margin of 4.27% and a return on equity of 27.13%. The firm had revenue of $678.50 million during the quarter, compared to analysts’ expectations of $633.96 million. During the same period in the prior year, the company posted $1.09 EPS. The company’s revenue was up 12.8% on a year-over-year basis. analysts expect that Varian Medical Systems will post 4.31 EPS for the current year.
In other Varian Medical Systems news, SVP John W. Kuo sold 7,991 shares of the company’s stock in a transaction that occurred on Monday, January 8th. The shares were sold at an average price of $110.65, for a total value of $884,204.15. Following the completion of the transaction, the senior vice president now directly owns 27,363 shares in the company, valued at approximately $3,027,715.95. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Kolleen T. Kennedy sold 1,089 shares of the company’s stock in a transaction that occurred on Friday, January 12th. The shares were sold at an average price of $108.19, for a total transaction of $117,818.91. Following the completion of the transaction, the executive vice president now owns 27,751 shares of the company’s stock, valued at $3,002,380.69. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 90,568 shares of company stock valued at $10,905,313. Corporate insiders own 0.78% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “Somewhat Positive News Coverage Somewhat Unlikely to Impact Varian Medical Systems (VAR) Stock Price” was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this story on another website, it was stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this story can be read at https://www.dispatchtribunal.com/2018/04/08/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-varian-medical-systems-var-stock-price.html.
Varian Medical Systems Company Profile
Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Varian Particle Therapy. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy.
Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.